Cary J Claiborne - Net Worth and Insider Trading
Cary J Claiborne Net Worth
The estimated net worth of Cary J Claiborne is at least $51,552 dollars as of 2024-11-13. Cary J Claiborne is the Former Chief Financial Officer of Sucampo Pharmaceuticals Inc and owns about 2,864 shares of Sucampo Pharmaceuticals Inc (SCMP) stock worth over $51,552. Details can be seen in Cary J Claiborne's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cary J Claiborne has not made any transactions after 2014-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cary J Claiborne
Cary J Claiborne Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cary J Claiborne owns 2 companies in total, including Adial Pharmaceuticals Inc (ADIL) , and LadRx Corp (LADX) .
Click here to see the complete history of Cary J Claiborne’s form 4 insider trades.
Insider Ownership Summary of Cary J Claiborne
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ADIL | Adial Pharmaceuticals Inc | 2021-11-02 | director |
LADX | LadRx Corp | 2022-07-27 | director |
Cary J Claiborne Latest Holdings Summary
Cary J Claiborne currently owns a total of 1 stock. Cary J Claiborne owns 2,864 shares of Sucampo Pharmaceuticals Inc (SCMP) as of December 16, 2014, with a value of $51,552.
Latest Holdings of Cary J Claiborne
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SCMP | Sucampo Pharmaceuticals Inc | 2014-12-16 | 2,864 | 18.00 | 51,552 |
Holding Weightings of Cary J Claiborne
Cary J Claiborne Form 4 Trading Tracker
According to the SEC Form 4 filings, Cary J Claiborne has made a total of 0 transactions in Sucampo Pharmaceuticals Inc (SCMP) over the past 5 years. The most-recent trade in Sucampo Pharmaceuticals Inc is the sale of 50,000 shares on December 16, 2014, which brought Cary J Claiborne around $645,500.
Insider Trading History of Cary J Claiborne
- 1
Cary J Claiborne Trading Performance
Cary J Claiborne Ownership Network
Ownership Network List of Cary J Claiborne
Ownership Network Relation of Cary J Claiborne
Cary J Claiborne Owned Company Details
What does Adial Pharmaceuticals Inc do?
Who are the key executives at Adial Pharmaceuticals Inc?
Cary J Claiborne is the director of Adial Pharmaceuticals Inc. Other key executives at Adial Pharmaceuticals Inc include director & 10 percent owner & Chief Executive Officer Stilley William B. Iii , director & 10 percent owner Bankole A. Johnson , and COO and CFO Joseph Truluck .
Adial Pharmaceuticals Inc (ADIL) Insider Trades Summary
Over the past 18 months, Cary J Claiborne made no insider transaction in Adial Pharmaceuticals Inc (ADIL). Other recent insider transactions involving Adial Pharmaceuticals Inc (ADIL) include a net purchase of 700 shares made by Kevin Schuyler ,
In summary, during the past 3 months, insiders sold 0 shares of Adial Pharmaceuticals Inc (ADIL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adial Pharmaceuticals Inc (ADIL) were sold and 700 shares were bought by its insiders, resulting in a net purchase of 700 shares.
Adial Pharmaceuticals Inc (ADIL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adial Pharmaceuticals Inc Insider Transactions
Cary J Claiborne Mailing Address
Above is the net worth, insider trading, and ownership report for Cary J Claiborne. You might contact Cary J Claiborne via mailing address: 3056 Seneca Chief Trail, Ellicott City Md 21042.